Current Status of Centrally Acting Peptides PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Current Status of Centrally Acting Peptides PDF full book. Access full book title Current Status of Centrally Acting Peptides by B. N. Dhawan. Download full books in PDF and EPUB format.
Author: B. N. Dhawan
Publisher: Pergamon
ISBN:
Category : Medical
Languages : en
Pages : 296
Get Book Here
Book Description
Hardbound. An exhaustive and up to date critical review of centrally acting peptides, including review articles and previously unpublished results from twenty laboratories in various parts of the world
Author: B. N. Dhawan
Publisher: Pergamon
ISBN:
Category : Medical
Languages : en
Pages : 296
Get Book Here
Book Description
Hardbound. An exhaustive and up to date critical review of centrally acting peptides, including review articles and previously unpublished results from twenty laboratories in various parts of the world
Author: John Hughes
Publisher: Springer
ISBN: 1349036684
Category : Medical
Languages : en
Pages : 258
Get Book Here
Book Description
Author: Hubert Vaudry
Publisher: Frontiers Media SA
ISBN: 2889455378
Category :
Languages : en
Pages : 282
Get Book Here
Book Description
Regulatory peptides represent the most diverse and versatile family of messenger molecules. They are produced by all living organisms from bacteria to mammals. They are involved in a wide variety of biological functions. Biologically active peptides and their receptors thus constitute an unlimited source of inspiration for the development of innovative drugs and cosmetics. The present eBook is a unique collection of research articles and reviews that provide a representative examplification of the latest progress in regulatory peptide research.
Author:
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 520
Get Book Here
Book Description
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1442
Get Book Here
Book Description
First multi-year cumulation covers six years: 1965-70.
Author: National Institute on Drug Abuse
Publisher:
ISBN:
Category : Clinical chemistry
Languages : en
Pages : 250
Get Book Here
Book Description
Author: Ved Srivastava
Publisher: Royal Society of Chemistry
ISBN: 1788014332
Category : Science
Languages : en
Pages : 572
Get Book Here
Book Description
Peptide therapy has become a key strategy in innovative drug development, however, one of the potential barriers for the development of novel peptide drugs in the clinic is their deficiencies in clearly defined chemistry, manufacturing and controls (CMC) strategy from clinical development to commercialization. CMC can often become a rate-limiting step due to lack of knowledge and lack of a formal policy or guidelines on CMC for peptide-based drugs. Regulators use a risk-based approach, reviewing applications on a case-by-case basis. Peptide Therapeutics: Strategy and Tactics for Chemistry, Manufacturing, and Controls covers efficient manufacturing of peptide drug substances, a review of the process for submitting applications to the regulatory authority for drug approval, a holistic approach for quality attributes and quality control from a regulatory perspective, emerging analytical tools for the characterisation of impurities, and the assessment of stability. This book is an essential reference work for students and researchers, in both academia and industry, with an interest in learning about CMC, and facilitating development and manufacture of peptide-based drugs.
Author:
Publisher:
ISBN:
Category : Science
Languages : en
Pages : 596
Get Book Here
Book Description
Author: 国立国会図書館 (Japan)
Publisher:
ISBN:
Category : Science
Languages : en
Pages : 672
Get Book Here
Book Description
Author: Ved Srivastava
Publisher: Royal Society of Chemistry
ISBN: 1782627324
Category : Medical
Languages : en
Pages : 589
Get Book Here
Book Description
With potentially high specificity and low toxicity, biologicals offer promising alternatives to small-molecule drugs. Peptide therapeutics have again become the focus of innovative drug development efforts backed up by a resurgence of venture funds and small biotechnology companies. What does it take to develop a peptide-based medicine? What are the key challenges and how are they overcome? What are emerging therapeutics for peptide modalities? This book answers these questions with a holistic story from molecules to medicine, combining the themes of design, synthesis and clinical applications of peptide-based therapeutics and biomarkers. Chapters are written and edited by leaders in the field from industry and academia and they cover the pharmacokinetics of peptide therapeutics, attributes necessary for commercially successful metabolic peptides, medicinal chemistry strategies for the design of peptidase-resistant peptide analogues, disease classes for which peptide therapeutic are most relevant, and regulatory issues and guidelines. The critical themes covered provide essential background information on what it takes to develop peptide-based medicine from a chemistry perspective and views on the future of peptide drugs. This book will be a valuable resource not only as a reference book for the researcher engaged in academic and pharmaceutical setting, from basic research to manufacturing and from organic chemistry to biotechnology, but also a valuable resource to graduate students to understand discovery and development process for peptide-based medicine.
